Literature DB >> 9035171

Body growth in primary de Toni-Debré-Fanconi syndrome.

D Haffner1, A Weinfurth, C Seidel, F Manz, H Schmidt, R Waldherr, H J Bremer, O Mehls, K Schärer.   

Abstract

Body growth in nine children with primary de Toni-Debré-Fanconi syndrome was followed from birth to adolescence or adult life. At the time of diagnosis, corresponding to the start of treatment, the median age was 2.3 (range 0.4-13.9) years and height standard deviation score (SDS) was always decreased (median -3.5, range -6.8 to -2.1). Despite continuous electrolyte and bicarbonate supplementation only four patients showed a slight improvement in growth. At the time of the last observation at the age of 17.2 (4.5-20.1) years median height was -4.7 (-5.9 to -1.8) SDS. The median difference between height at last observation and target height was -4.5 SDS. Final height (n = 5) ranged between -1.8 and -5.5 (median -4.3) SDS. The pubertal growth spurt was absent in two children. Metabolic acidosis was identified as a significant growth-retarding factor. Mean serial blood bicarbonate levels and height SDS at the last observation were correlated (r = -0.87, P < 0.01). No correlation was observed between last height SDS and the degree of hypokalemia, hypophosphatemia, or hypercalciuria. In conclusion, patients with primary de Toni-Debré-Fanconi-syndrome present severe growth failure at the time of diagnosis which persists into adult life. Supportive therapy is frequently unable to prevent further loss of relative height.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9035171     DOI: 10.1007/s004670050230

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  3 in total

1.  Growth hormone therapy for a patient with idiopathic Fanconi syndrome and growth hormone deficiency.

Authors:  Takayuki Okamoto; Yasuyuki Sato; Takeshi Yamazaki; Asako Hayashi; Toshiyuki Takahashi
Journal:  CEN Case Rep       Date:  2017-02-09

2.  Comparison of growth in primary Fanconi syndrome and proximal renal tubular acidosis.

Authors:  Shu-Yeh Hsu; I-Jung Tsai; Yong-Kwei Tsau
Journal:  Pediatr Nephrol       Date:  2005-02-10       Impact factor: 3.714

Review 3.  Longitudinal growth in chronic hypokalemic disorders.

Authors:  Helena Gil-Peña; Natalia Mejia; Oscar Alvarez-Garcia; Vanessa Loredo; Fernando Santos
Journal:  Pediatr Nephrol       Date:  2009-11-10       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.